Approvals/TGA/OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial

Approved

STANDARD

OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial

Samsung Bioepis AU Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: dba6cf126e6f68ec
Product Name: OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial
Artg Id: 456527
Artg Name: OPUVIZ aflibercept 40 mg/mL solution for intravitreal injection in vial
Sponsor: Samsung Bioepis AU Pty Ltd
Company Detail Path: /organization/samsung-bioepis-au-pty-ltd
Artg Date: 2025-09-18
Registration Type: Medicine
Therapeutic Good Type: Medicines
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

dba6cf126e6f68ec

Type

Standard